Physician profile
Faheemullah Beg
NPI 1801209614
$9,623.33
in general payments reported to CMS, 2019-2025
44 companies · $882 in 2025
The $882 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,601 · 2020: $1,604 · 2021: $1,226 · 2022: $2,003 · 2023: $1,437 · 2024: $872 · 2025: $882.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,190.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,313.11 | 2019-2025 | Eluvia, Cds - Mct/Cem Monitoring, Avvigo Guidance System |
| Pfizer INC. | $1,007.64 | 2019-2025 | |
| Abbott Laboratories | $855.52 | 2019-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Biosense Webster, INC. | $785.56 | 2021-2023 | Carto 3 |
| Novartis Pharmaceuticals Corporation | $572.06 | 2021-2025 | |
| Shockwave Medical, INC | $380.34 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Merck Sharp & Dohme LLC | $351.49 | 2021-2025 | Verquvo |
| Janssen Pharmaceuticals, INC | $324.31 | 2021-2024 | Xarelto |
| Medtronic Vascular, INC. | $295.14 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $292.46 | 2022-2023 | Jardiance |
| Amgen INC. | $280.28 | 2020-2025 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $186.17 | 2022-2024 | Camzyos, Eliquis |
| Abiomed | $179.60 | 2020-2025 | Impella |
| Astrazeneca Pharmaceuticals LP | $177.22 | 2022-2024 | Farxiga |
| Actelion Pharmaceuticals US, INC. | $164.55 | 2021-2024 | Opsumit, Uptravi |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $164.44 | 2021 | |
| Philips North America LLC | $111.66 | 2022-2025 | (Ck4) Mcot, Ecc Solutions |
| Terumo Medical Corporation | $109.91 | 2022 | |
| Baxter Healthcare | $99.99 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor |
| Novo Nordisk INC | $83.57 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Stryker Corporation | $83.39 | 2025 | Flowtriever, Clottriever Bold Catheter |
| Alnylam Pharmaceuticals INC. | $82.52 | 2025 | Amvuttra |
| Astellas Pharma US INC | $79.39 | 2019 | |
| Esperion Therapeutics, INC. | $61.47 | 2021-2023 | Nexletol |
| Sanofi-Aventis U.S. LLC | $60.04 | 2021-2023 | |
| Inari Medical, INC. | $44.68 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Silk Road Medical, INC. | $40.99 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Lexicon Pharmaceuticals, INC. | $40.25 | 2023-2024 | Inpefa |
| Irhythm Technologies, INC. | $36.66 | 2022 | |
| Getinge USA Sales, LLC | $36.10 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $30.47 | 2022-2023 | |
| United Therapeutics Corporation | $30.36 | 2019 | |
| Bardy Diagnostics, INC. | $30.00 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $29.55 | 2021-2022 | |
| Cardiva Medical, INC. | $28.64 | 2025 | Cardiva Vascade 6/7f Vcs |
| Edwards Lifesciences Corporation | $26.23 | 2019 | |
| Chiesi USA, INC. | $21.52 | 2020 | |
| Amarin Pharma, INC. | $19.67 | 2022 | |
| Heartflow, INC. | $19.55 | 2024 | |
| Angiodynamics, INC. | $19.12 | 2021 | |
| Mallinckrodt Hospital Products INC. | $18.94 | 2020 | |
| Bridgebio Pharma, INC. | $18.45 | 2025 | Attruby |
| Kestra Medical Technology Services, INC. | $16.62 | 2025 | Assure Wcd |
| Regeneron Healthcare Solutions, INC. | $13.70 | 2023 | Evkeeza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Faheemullah Beg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.